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Background
Little is known about the efficacy of “RT” (referral to
treatment) for increasing receipt of substance use disor-
der (SUD) treatment by patients with unhealthy drug
use identified by screening. We compared receipt of
SUD treatment between baseline and 6 months across
three randomized groups: no intervention and two dif-
ferent types of brief interventions.
Material and methods
Adults presenting to a hospital-based primary care clinic
with recent drug use (Alcohol, Smoking and Substance
Involvement Screening Test [ASSIST] drug specific scores
of ¿4) were enrolled in a randomized clinical trial compar-
ing: (1) a 10-15 minute structured interview conducted by
health educators (BNI), (2) a 30-45 minute intervention
based on motivational interviewing by Masters-level coun-
selors (MOTIV), or 3) no brief intervention. All received
information on treatment resources. We assessed receipt
of any SUD treatment in a statewide database. Logistic
regression analyses adjusted for main drug (self-identified),
drug dependence, and past SUD treatment.
Results
Among 528 participants the main drug was marijuana
(63%), cocaine (19%), and opioids (17%); 46% met 12-
month drug dependence criteria (Composite Interna-
tional Diagnostic Interview Short Form); 18% had
ASSIST scores (¿27) consistent with dependence (past
3-months). At 6 months, 14% (73/528) received any
SUD treatment. There were no significant differences in
SUD treatment receipt: BNI vs control (adusted odds
ratio [AOR] 1.16, 95% Confidence Interval [CI] 0.59,
2.30, Hochberg adjusted p-value=0.66); MOTIV vs con-
trol (AOR 0.45, 95%CI: 0.21, 0.97, Hochberg adjusted
p-value=0.08). There were no significant interactions
between intervention and main drug, severity (ASSIST),
or prior SUD treatment.
Conclusions
Brief intervention did not increase receipt of SUD treat-
ment in primary care patients. Future research should
address how to make referral to treatment successful
among screen-identified patients who could benefit
from it.
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